2[1]Ferrannini E. Insulin resistance versus insulin deficiency in noninsulin- dependent diabetes mellitus: problems and prospects.Endocr Rev, 1998, 19:477～490.
3[2]Zhu X, Pan C, Shi H, et al. Rosiglitazone in combination with sulfonylurea improves glycemic control in Chinese type 2 diabetes patients. Abstract Poster (0624) Presentation ICE, 2000, Syd ney.
4[3]Patel J, Weston W, Hemyari P. Rosiglitazone(RSG) decreases insulin resistance(IR) and improves beta- cell function(BCF) in patients with type 2 diabetes mellitus. Program and Abstracts:Endocrine Society 81st annual Meeting, 1999, 470:3～153.
5Storlien LH, James DE, Burleigh KM, et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol, 1986, 251(5 Pt 1):E576-E583.
6McGarry JD. Banting lecture 2001:dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes,2002,51:7-18.
7Lee Y,Hirose H, Ohneda M,et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A, 1994,91: 10878-10882.
8Randle PJ,Garland PB,Hales CN, et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1963,1: 785-789.
9Boden G, Chen X, Ruiz J, et al. Mechanism of fatty acid-induced inhibition of glucose uptake. J Clin Invest, 1994, 93: 2438-2446.
10Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and huperinsulinemia. J Clin Endocrinol Metab, 2001,86:1930-1935.
